Hans Blaauwgeers
Hans Blaauwgeers publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Medical Imaging and Pathology Studies.
- World rank
- #1,528,112 of 7,710,434 ranked researchers
- Rank in Netherlands
- #34,264 of 107,149
- Works
- 35
- Citations
- 890
- Citations per work
- 25.4
What does Hans Blaauwgeers research?
Hans Blaauwgeers's work is mostly in Medicine (65%), Immunology and Microbiology (5%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2365.3%
- Medicine2365.3%
- Everything else926.2%
- Life Sciences38.5%
- 1Pulmonary and Respiratory Medicine47% of their works
- 2Oncology8% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Immunology5% of their works
- 5Surgery3% of their works
- 6Cancer Research3% of their works
Research topics
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Radiomics and Machine Learning in Medical Imaging
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cancer Genomics and Diagnostics
- RNA modifications and cancer
- Immune Cell Function and Interaction
Which keywords describe Hans Blaauwgeers's research?
The keywords of their largest research topics: CT Screening, Lung Cancer, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Medical Imaging, Pulmonary Alveolar Microlithiasis and Pulmonary Sclerosing Hemangioma.
- RNA methylation
- NK Cell Recognition
- Cancer Genomics
- Fibrosis
- Pulmonary Sclerosing Hemangioma
- Medical Imaging
- ALK Inhibitors
- Lung Cancer
- CT Screening
- Targeted Therapy
- EGFR Mutations
- Pulmonary Alveolar Microlithiasis
- Radiomics
- Idiopathic Pulmonary Fibrosis
- Mutational Signatures
- Natural Killer Cells
- m6A-seq
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- CT Screening191 topic
- Lung Cancer191 topic
- Targeted Therapy142 topics
- ALK Inhibitors111 topic
- EGFR Mutations111 topic
- Medical Imaging51 topic
- Pulmonary Alveolar Microlithiasis51 topic
- Pulmonary Sclerosing Hemangioma51 topic
- Radiomics51 topic
- Fibrosis41 topic
- Idiopathic Pulmonary Fibrosis41 topic
- Cancer Genomics31 topic
- Mutational Signatures31 topic
- NK Cell Recognition21 topic
- Natural Killer Cells21 topic
- RNA methylation21 topic
- m6A-seq21 topic
Where does Hans Blaauwgeers work?
Hans Blaauwgeers's main affiliation in the publication record is OLVG, Netherlands.
How many publications and citations does Hans Blaauwgeers have?
OpenAlex counts 35 works and 890 citations for Hans Blaauwgeers, an h-index of 11, ranking #1,528,112 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hans Blaauwgeers. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.